Navigation Links
Sea Creature's Toxin Could Lead to Promising Cancer Treatment

A toxin derived from a reclusive sea creature resembling a translucent doughnut has inspired UT Southwestern Medical Center researchers to develop //a related compound that shows promise as a cancer treatment.

In a study appearing online this week in the Proceedings of the National Academy of Sciences, the UT Southwestern scientists detail how the toxin blocks uninhibited reproduction of cultured human cancer cells while leaving healthy cells unaffected.

An accompanying study in PNAS shows that, in pre-clinical trials, a synthetic form of the toxin reduced human tumors implanted in mice without the harmful side effects seen using other cancer drugs. “Diazonamide is a special molecule – it’s teaching us more than we imagined,” said Dr. Patrick Harran, professor of biochemistry and a senior author on both studies.

“This is a truly exciting result,” said Dr. John Schwab, a program officer at the National Insti tutes of Health’s National Institute of General Medical Sciences, which partly funded the work. “Not only has this UT Southwestern team identified a potent anti-cancer drug, but its unique mode of action avoids the kinds of side effects that make cancer chemotherapy so difficult. It’s a great example of how NIH support for fundamental chemical research can benefit the American health-care consumer.”

The animal, Diazona angulata, is a sea squirt a few inches wide that lives in colonies anchored to rocks. It was discovered offshore of the Philippines in 1990 as scientists were looking for species that might lead to useful drugs. From a few specimens, scientists extracted a tiny amount of a toxin, diazonamide A, which the animal probably uses to repel predators.

The toxin proved to kill cancer cells in culture, but so little of its natural form was available that a race soon began to synthesize it in the laboratory.

A chemical structure for diazonamide A was published in 1991, but in 2001, Dr.
'"/>




Page: 1 2 3

Related medicine news :

1. Toxins linked with pregnancy loss
2. Toxin connected to Flesh-eating Pneumonia in Kids
3. Vegetables decrease Tobacco Toxins
4. Toxin injections support stroke associated spasticity
5. Indians Stay Away from Coke, Pepsi After Toxin Scare
6. Toxin from the sea to relieve pain
7. Toxin Identified For Alzheimer’s Diseas
8. UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply
9. Gold Nanoparticles Are Good Detectors Biological Toxins
10. Appearance Of Facial Scars Improved By Botulinum Toxin
11. "Beach to Bedside" Study Focuses on Effects of Inhaled Toxins
Post Your Comments:
(Date:11/20/2008)...ewswire-USNewswire/ -- The National Minority Quali...al Association,s recent decision to develop a Heal... and patient advocates to join the Forum in encour...plans. , , "Physicians and lawyers -- even ...Puckrein, PhD, President and Chief Executive Offic...
(Date:11/20/2008)...ewswire/ -- Precision Therapeutics Inc., a leader,...sts, has secured $43 million,in additional fundin...of,ChemoFx(R). ChemoFx is a diagnostic test that...therapeutic regimen for cancer patients. New inve...ound and was joined by existing,investors Adams C...
(Date:11/20/2008)...ewswire/ -- Precyse Solutions, the leader in,driv...rmance through,technology and management solution...il of Pennsylvania as "Technology Company of the Y...e Kimmel Center. The Annual Gala honors the,regi...d entrepreneurs. More,than 1200 business leaders...
(Date:11/20/2008)...ewswire-USNewswire/ -- In a historic step toward a...or financing long-term services and supports, the ...nd the Consortium for Citizens with Disabilities (...reform. , , Together, the two coalitions r...rs, people with disabilities, and providers of hea...
Breaking Medicine News(10 mins):Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 3Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 4
... the scientists at the Glasgow University, English...oxidants that offer protection against stroke, hea... as effective as an apple in keeping the doctor aw... effects by getting 12 volunteers to drink a pint ...
...ersions of High-tech laboratory tools such as comp...ed publicly. The NIH grantees have developed a sec...e MitoChip v2.0. This can for the first time seque...heir report will be published in the September iss...
...ed an important milestone in the development of st...lds first ever vaccine for cervical cancer, named ... in the cap of Professor Frazer, a scientist in Qu...ccine, who has relentlessly worked on this working...
...d by biologists from the University of California,...sponsible to pick up the ‘sour’ taste,// which is ...study, featured on the cover of the August 24 issu...each of the five basic tastes is detected by disti...
Other Medicine News:Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 2Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 3Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 4Health News:Discerning Sour Taste 2Health News:Discerning Sour Taste 3
(Date:11/20/2008)...PRNewswire/ -- Milk. It does a body good. And,now.... After years of,research, scientists at OncoNutr... milk that stimulate the body,s own production of ...News Release, go to:, http://www.prnewswire.com/mn...g new cancer therapies, the chief scientist, Dr. D...
(Date:11/20/2008)...RNewswire-FirstCall/ -- Duska Therapeutics,Inc.,...it has submitted its,pivotal Phase 3 ATPace clini...tocol Assessment (SPA) procedure with the U.S. Foo... to securing an agreement with the FDA, Duska inte...nd, placebo-controlled and randomized Phase 3,cli...
(Date:11/20/2008)...e/ -- Clinical data from a prospective,registry p...ium shows DVT,treatment with the Trellis(R) Perip... (Santa Clara, CA) successfully breaks up the bloo... This technique, called isolated pharmacomecha...kly and safely than current catheter-directed thro...
(Date:11/20/2008)... 20 The Scandinavian-based drug,d...esults of studies on its,lead antimicrobial candi...,the studies showed that the novel lytic peptido...significantly better towards killing Staphylococcu... gold standard drugs. In,addition to this it has ...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 1US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 5Vaccine may double survival in patients with deadly brain tumors 20841 1Vaccine may double survival in patients with deadly brain tumors 20841 2Report confirms increased risk of smoking substance abuse in bipolar adolescents 20838 1Report confirms increased risk of smoking substance abuse in bipolar adolescents 20838 2Researchers identify proteins making up mechanosensitive ion channels 20834 1Researchers identify proteins making up mechanosensitive ion channels 20834 2Researchers identify proteins making up mechanosensitive ion channels 20834 3
...ta being presented today at Digestive Disease Week... Microbia today,announced the presentation of data...ated colonic transit and improved bowel function,i...e bowel syndrome,(IBS-C). These data also showed l... of adverse events. Linaclotide is a first-in-clas...
...ings Show Compliance with Medication Instructions ...tion, Lifestyle,Management and More Healthcare Pro...NEW YORK, May 19, 2007 /PRNewswire/ -- Results of ...e Hypertension Education,Foundation (HEF) were pre...c. (ASH) Twenty-Second Annual Scientific Meeting,a...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 2Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 5Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 6Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 7
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology.
...Pathology and Laboratory Medicine at the Cleveland...rehensive academic medical center laboratories. Wi...0 pathologists and PhDs, our laboratories generate...ations and diagnostic consultations annually. Our ...
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom
Medicine Products: